Although the role of the mtDNA-cGAS-STING pathway in the CNS has only been partially revealed in recent years, its potential as an emerging target for AD treatment has gradually become apparent, and its significance and prospective utility cannot be ignored. Here, STING1 is linked to Alzheimer disease.